ESVNF (Apptly Health Technologies) YoY EBITDA Growth: 0.00% (As of Jan. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ESVNF Apptly Health Technologies Corp ESVNF
13 GF Score
Price $0.10
View Full Analysis

What is Apptly Health Technologies YoY EBITDA Growth?

Apptly Health Technologies ESVNF 13 YoY EBITDA Growth is 0.00% as of Jan. 2026. GuruFocus rates ESVNF with a GF Score™ of 13/100.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Apptly Health Technologies's YoY EBITDA Growth for the quarter that ended in Jan. 2026 was 0.00%.

Apptly Health Technologies's EBITDA per Share for the three months ended in Jan. 2026 was $-0.00.

Apptly Health Technologies YoY EBITDA Growth Related Terms

Apptly Health Technologies YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Apptly Health Technologies's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apptly Health Technologies YoY EBITDA Growth Chart

Apptly Health Technologies Annual Data
Trend Dec23
YoY EBITDA Growth
0.00

Apptly Health Technologies Quarterly Data
Dec23 Dec24 Jan26
YoY EBITDA Growth 0.00 0.00 0.00
ESVNF
13GF Score
Apptly Health Technologies Corp ESVNF
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apptly Health Technologies YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Apptly Health Technologies's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: . 20 ))/ | EBITDA per Share (A: . 20 ) |
=(-0.009-)/ | |
=N/A %

Apptly Health Technologies's YoY EBITDA Growth for the quarter that ended in Jan. 2026 is calculated as:

YoY EBITDA Growth (Q: Jan. 2026 )
=(EBITDA per Share (Q: Jan. 2026 )-EBITDA per Share (Q: . 20 )) / | EBITDA per Share (Q: . 20 )) |
=(-0.002-)/ | |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 0.00% mean?
Apptly Health Technologies (ESVNF) has a YoY EBITDA Growth of 0.00% as of Jan. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Apptly Health Technologies and its competitors.
Is Apptly Health Technologies' YoY EBITDA Growth too high?
Apptly Health Technologies' current YoY EBITDA Growth is 0.00%. Overall, Apptly Health Technologies has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Apptly Health Technologies' YoY EBITDA Growth compare to VEEV and BTSG?
Apptly Health Technologies' YoY EBITDA Growth of 0.00% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Healthcare Providers & Services company?
A good YoY EBITDA Growth depends on the Healthcare Providers & Services industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Apptly Health Technologies and its competitors. Apptly Health Technologies's current YoY EBITDA Growth is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apptly Health Technologies stock overvalued right now?
Apptly Health Technologies (ESVNF) has a current YoY EBITDA Growth of 0.00%. The current YoY EBITDA Growth is 0.00%. Apptly Health Technologies' overall GF Score™ is 13/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Apptly Health Technologies (ESVNF), the current YoY EBITDA Growth is 0.00% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Apptly Health Technologies Business Description

Other Exchanges 4KL0:GermanyAPPT:Canada
Address 918 - 1030 West Georgia Street, Vancouver, BC, CAN, V6E 2Y3
UBERDOC Health Technologies Corp is a healthcare-focused investment company. It operates a healthcare marketplace that connects patients directly with physicians and specialists across multiple medical fields in the U.S. It provides access to care without referral or insurance barriers. Its platform is designed to support patient access to healthcare and to assist physicians in managing their practices.
13GF Score

Get the complete analysis for ESVNF

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.10
Price